期刊
EXPERIMENTAL CELL RESEARCH
卷 416, 期 1, 页码 -出版社
ELSEVIER INC
DOI: 10.1016/j.yexcr.2022.113150
关键词
Ovarian cancer; Mouse models; Organoids; Microfluidics
资金
- Hong Kong Research Grant Council [17104820, 17105919]
- Health and Medical Research Fund [06173496, 08192286]
- Laboratory for Synthetic Chemistry and Chemical Biology under the Health@InnoHK Program
- Croucher Foundation Senior Research Fellowship
Ovarian cancer has the highest mortality rate among gynecological malignancies due to high therapeutic resistance, prolonged latency, and a lack of effective treatments. Preclinical models that recapitulate the histological, molecular, and pathophysiological features of distinct ovarian cancer subtypes, especially patient-derived models, are valuable assets in addressing the heterogeneity of ovarian cancer and providing important insights for personalized treatments. Further optimization of these models will enhance their clinical translatability in ovarian cancer research.
Among all gynecological malignancies, ovarian cancer (OC) accounts for the highest mortality rate due to high therapeutic resistance, prolonged latency and a lack of effective treatments. This calls for preclinical models that could recapitulate the histological, molecular and pathophysiological features of distinct OC subtypes. Various mouse models including tumor xenografts, genetically modified models, and novel 3D tumor models including organoids and organotypic co-culture models have been developed, and they serve as valuable assets to fulfill this demand. These models, particularly those patient-derived, can address the heterogeneity of OC and simulate OC progression in patients, hence bringing important insights for personalized treatments. In this review, we will discuss the merits and challenges of these models, and summarize their current preclinical applications in patient stratification and therapeutic research. Though limitations are inevitable, further optimization will render these models more clinically translatable in OC research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据